2021 ICD-10-CM Code C15.4

Malignant neoplasm of middle third of esophagus

Version 2021
Billable Code
MS-DRG Mapping
Neoplasm Malignant Primary

Valid for Submission

C15.4 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of middle third of esophagus. The code C15.4 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.

The ICD-10-CM code C15.4 might also be used to specify conditions or terms like carcinoma of middle third of esophagus, carcinoma of thoracic part of esophagus, malignant tumor of middle third of esophagus, malignant tumor of thoracic part of esophagus, neoplasm of middle third of esophagus , neoplasm of thoracic esophagus, etc.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic esophagus middle (third) or Neoplasm, neoplastic esophagus thoracic .

ICD-10:C15.4
Short Description:Malignant neoplasm of middle third of esophagus
Long Description:Malignant neoplasm of middle third of esophagus

Code Classification

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Convert C15.4 to ICD-9 Code

The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code C15.4 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.

Table of Neoplasms

The code C15.4 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »esophagus
    »middle (third)
C15.4C78.89D00.1D13.0D37.8D49.0
»Neoplasm, neoplastic
  »esophagus
    »thoracic
C15.4C78.89D00.1D13.0D37.8D49.0

Information for Patients


Esophageal Cancer

The esophagus is a hollow tube that carries food and liquids from your throat to your stomach. Early esophageal cancer usually does not cause symptoms. Later, you may have symptoms such as

You're at greater risk for getting esophageal cancer if you smoke, drink heavily, or have acid reflux. Your risk also goes up as you age

Your doctor uses imaging tests and a biopsy to diagnose esophageal cancer. Treatments include surgery, radiation, and chemotherapy. You might also need nutritional support, since the cancer or treatment may make it hard to swallow.

NIH: National Cancer Institute


[Learn More]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)